I feel Pharmeasy has got a lot of unwarranted critique and bad press in the last 6 months. I agree, they went overboard with acqusitions and debt but with the 90 percent valuation cut and the succesful rights issue i feel the company is decently priced now. I have given a decent 10 percent plus weightage at the rights issue price and slightly higher.Im happy to invest at a 7000-10000 cr market cap for a business which can only keep growing and eventually become profitable. I am ready to give this company at least 3 years and looking forward to their IPO whenever it happens.
Subscribe To Our Free Newsletter |